Malaria during pregnancy and foetal haematological status in Blantyre, Malawi

listen audio

Study Justification:
– The study aimed to investigate the impact of maternal malaria on foetal haemoglobin levels and markers of foetal immune activation.
– It addressed the hypothesis that lower cord haemoglobin values in malarious regions were a result of foetal immune activation to maternal malaria.
– The study aimed to provide insights into the relationship between maternal malaria, foetal haemoglobin levels, and birth outcomes.
Study Highlights:
– The study included 32 malaria-infected and 58 uninfected pregnant women in Blantyre, Malawi.
– Maternal malaria was associated with a reduction in maternal haemoglobin levels, but no significant effect on cord haemoglobin levels was found.
– Cord blood markers of haematological and hypoxic statuses did not differ between malaria-infected and uninfected women.
– Maternal malaria was associated with decreased TGF-β and increased cord ferritin, which was positively correlated with parasitaemia.
– Increased cord ferritin was associated with significantly decreased birth weight and gestational length.
Study Recommendations:
– Further research is needed to understand the mechanisms behind the lack of effect of maternal malaria on cord haemoglobin levels.
– Future studies should explore the role of foetal immune activation in poor birth outcomes associated with maternal malaria.
– Strategies to prevent and treat maternal malaria should be prioritized to improve birth outcomes.
Key Role Players:
– Researchers and scientists specializing in malaria, obstetrics, and foetal health.
– Healthcare providers and clinicians involved in antenatal care and delivery.
– Public health officials and policymakers responsible for implementing malaria prevention and control programs.
– Community health workers and educators who can disseminate information about malaria prevention and antenatal care.
Cost Items for Planning Recommendations:
– Research funding for conducting further studies on the impact of maternal malaria on foetal haemoglobin levels and birth outcomes.
– Budget for training healthcare providers and community health workers on malaria prevention and antenatal care.
– Resources for implementing malaria prevention and control programs, including distribution of insecticide-treated bed nets and antimalarial medications.
– Funding for public health campaigns and educational materials to raise awareness about the importance of antenatal care and malaria prevention during pregnancy.

The strength of evidence for this abstract is 7 out of 10.
The evidence in the abstract is moderately strong. The study examined cord haemoglobin levels in relation to maternal malaria, anaemia, and markers of foetal immune activation. It found that cord haemoglobin levels were protected from the effect of maternal malaria, but decreased TGF-β and elevated ferritin levels in cord blood suggest foetal immune activation to maternal malaria. The study had a sample size of 90 pregnant women and used various measurements and assays to collect data. To improve the evidence, future studies could consider increasing the sample size and conducting a randomized controlled trial to establish causality.

Background: Although maternal anaemia often stems from malaria infection during pregnancy, its effects on foetal haemoglobin levels are not straightforward. Lower-than-expected cord haemoglobin values in malarious versus non-malarious regions were noted by one review, which hypothesized they resulted from foetal immune activation to maternal malaria. This study addressed this idea by examining cord haemoglobin levels in relation to maternal malaria, anaemia, and markers of foetal immune activation. Methods: Cord haemoglobin levels were examined in 32 malaria-infected and 58 uninfected women in Blantyre, Malawi, in relation to maternal haemoglobin levels, malaria status, and markers of foetal haematological status, hypoxia, and inflammation, including TNF-α, TGF-β, and ferritin. All women were HIV-negative. Results: Although malaria was associated with a reduction in maternal haemoglobin (10.8 g/dL vs. 12.1 g/ dL, p < 0.001), no reduction in cord haemoglobin and no significant relationship between maternal and cord haemoglobin levels were found. Cord blood markers of haematological and hypoxic statuses did not differ between malaria-infected and uninfected women. Maternal malaria was associated with decreased TGF-β and increased cord ferritin, the latter of which was positively correlated with parasitaemia (r = 0.474, p = 0.009). Increased cord ferritin was associated with significantly decreased birth weight and gestational length, although maternal and cord haemoglobin levels and malaria status had no effect on birth outcome. Conclusion: In this population, cord haemoglobin levels were protected from the effect of maternal malaria. However, decreased TGF-β and elevated ferritin levels in cord blood suggest foetal immune activation to maternal malaria, which may help explain poor birth outcomes. © 2005 Abrams et al; licensee BioMed Central Ltd.

Ninety pregnant women pre-labor or in the latent phase of labor attending the Labour Ward, Queen Elizabeth Central Hospital, Blantyre, Malawi, were recruited from February to October 2002 as part of a prospective cohort study investigating the impact of maternal malaria on HIV vertical transmission [27]. All women with positive peripheral malaria blood smears in the larger study were enrolled, along with the next two sequential uninfected women. Women were excluded from this study if they had HIV, preeclampsia, or multiple gestations. Maternal socio-economic (marital status, educational level, maternal and paternal occupations, and house construction), health (antenatal clinic attendance and iron tablets usage) and anthropometric (height, weight, and mid-upper arm circumference (MUAC)) data were collected. Neonatal anthropometrics (head, abdominal, and arm circumferences, recumbent length, and weight) were evaluated within the first 24 hours after birth. Gestational age was determined by the New Ballard Score [28]. Maternal peripheral blood samples were taken at recruitment, and cord and placental samples were collected at delivery. Thick blood films were prepared from these samples for malaria microscopy. Placental blood was collected into EDTA by incising the cleaned maternal surface of the placenta and aspirating blood welling from the incision with a sterile pipette. Samples were separated within one hour, and plasma was stored at -70°C. Placental biopsies from a pericentric area (approximately 1 cm from the cord on the maternal side) were placed into 10% neutral buffered formalin to be used for placental malaria histopathology. Thick blood films were air-dried and Field's stained. Plasmodium falciparum malaria parasitaemia per μl was determined by counting parasites per 200 leukocytes, assuming 6000 leukocytes per μl [29]. Placental malaria histopathology was determined by SJR as described [13]; stage of infection and degree of malaria pigment in placental monocytes and fibrin were evaluated to determine disease severity [13]. For the purposes of data analysis, malaria infection was defined as either maternal (any parasites on maternal peripheral thick blood film) or placental (any parasites on placental thick blood film or histopathology). All subjects were consented and received HIV pre-test and post-test counseling before the onset of active labor. HIV status was determined by Serocard rapid test for HIV-1 and 2 (Trinity Biotech, Wicklow, Ireland) and Determine HIV1/2 (Abbott Diagnostics, Abbott Park, Illinois, USA); disagreement between tests was settled by HIV-SPOT ELISA (Genelabs Diagnostics, Singapore). Haemoglobin (Hb) concentration were measured in peripheral and cord blood samples using a Hemocue® haemoglobinometer (HemoCue AB, Ängelholm, Sweden); some results were not available as samples clotted. Maternal peripheral and cord plasma soluble transferrin receptor (sTfR) and ferritin were assayed by enzyme-linked immunosorbent assay (ELISA) kits according to manufacturer's instructions (Ramco Laboratories, Stafford, TX; and IBL, Hamburg, Germany; respectively). Data were analysed in Microsoft Excel using a log-log standard curve. Limits of detection were as follows: 1 μg/ml (sTfR) and 0.59 ng/ml (ferritin). Maternal peripheral, placental and cord plasma tumor necrosis factor-α (TNF-α) and transforming growth factor-β (TGF-β) and maternal peripheral and cord plasma C reactive protein (CRP) levels were also assayed by ELISA (R&D Systems, Minneapolis, MN, USA). Color was developed by SigmaFast o-phenylenediamine dihydrochloride tablets (Sigma, St. Louis, MO, USA). Data were analysed as described above. Limits of detection were as follows: 4 pg/ml (TNF-α), 13 pg/ml (TGF-β), and 1 μg/ml (CRP). Because scalp blood gas analysis, the most accurate means of assessing foetal hypoxia, was not feasible in the study setting, other proxies for chronic foetal hypoxia were measured: erythropoietin (Epo) [19], and cortisol and corticotrophin-releasing hormone (CRH) [20]. Maternal peripheral, placental, and cord plasma erythropoietin (Epo) levels were assayed by ELISA according to manufacturer's instructions (IBL, Hamburg, Germany). Placental and cord cortisol (CRT) and placental CRH were determined by ELISA as well (cortisol: R&D Systems, Minneapolis, MN, USA; CRH: Phoenix Pharmaceuticals, Belmont, CA, USA, respectively). Data were analysed as described above. Limits of detection were as follows: 0.4 mU/mL (EPO), 0.16 ng/ml (cortisol), and 0.19 ng/ml (CRH). This study was approved by the College of Medicine Research Committee, University of Malawi, and the Institutional Review Boards of the University of Michigan and the University of North Carolina. Data were entered in MS-Access and analyses were performed using SPSS v.10 and Intercooled Stata 8.0. Skewed data were log or (log+1) transformed before certain analyses. Maternal characteristics in malaria-infected and uninfected women (Table ​(Table2)2) were compared by t-tests (continuous variables) and chi-squared tests (dichotomous variables). Mann-Whitney U tests were used to compare maternal and cord characteristics in malaria-infected and uninfected women (Tables ​(Tables33 and ​and4).4). Bonferroni's method was used as a more conservative measure of significance for multiple comparisons [30]; p values reported reflect pre-adjustment values. The 5% significance level was used to determine significance. Maternal characteristics in women with and without maternal peripheral malaria infection Mann-Whitney U test of effect of maternal peripheral malaria on maternal and neonatal haematological and inflammatory status aIQR: Inter-quartile range b Significant after Bonferroni's adjustment for multiple comparisons. Mann-Whitney U test of effect of placental malaria on markers of neonatal haematological, inflammatory, and hypoxic status aIQR: Inter-quartile range

Based on the provided information, it is difficult to determine specific innovations for improving access to maternal health. The information provided describes a study conducted in Blantyre, Malawi, examining the impact of maternal malaria on foetal haemoglobin levels and birth outcomes. The study collected data on various maternal and neonatal characteristics, including socio-economic factors, health data, anthropometric measurements, and blood samples.

To improve access to maternal health, it is important to consider a range of factors, including healthcare infrastructure, availability of trained healthcare professionals, access to prenatal care, and education on maternal health. Some potential innovations that could be considered to improve access to maternal health include:

1. Mobile clinics: Implementing mobile clinics that travel to remote areas to provide prenatal care and health education to pregnant women who may not have easy access to healthcare facilities.

2. Telemedicine: Utilizing telemedicine technologies to provide remote consultations and prenatal care to pregnant women in areas with limited healthcare resources.

3. Community health workers: Training and deploying community health workers who can provide basic prenatal care, health education, and referrals to pregnant women in their communities.

4. Health education programs: Developing and implementing comprehensive health education programs that focus on prenatal care, nutrition, hygiene, and other important aspects of maternal health.

5. Improved transportation: Addressing transportation challenges by providing affordable and reliable transportation options for pregnant women to access healthcare facilities.

6. Strengthening healthcare infrastructure: Investing in the development and improvement of healthcare facilities, including maternity wards, to ensure that pregnant women have access to safe and quality care during pregnancy and childbirth.

7. Partnerships and collaborations: Establishing partnerships and collaborations between government agencies, non-profit organizations, and healthcare providers to pool resources and expertise to improve access to maternal health services.

It is important to note that these recommendations are general and may need to be tailored to the specific context and needs of the community or region in question.
AI Innovations Description
Based on the information provided, the recommendation to improve access to maternal health would be to implement a comprehensive antenatal care program that includes regular screening and treatment for malaria during pregnancy. This program should also focus on addressing anaemia in pregnant women, as it is often associated with malaria infection. Additionally, the program should include measures to monitor and manage markers of foetal immune activation, such as cord ferritin levels, to improve birth outcomes. The program should be implemented in collaboration with healthcare providers, researchers, and policymakers to ensure its effectiveness and sustainability.
AI Innovations Methodology
Based on the provided information, here are some potential recommendations to improve access to maternal health:

1. Increase access to antenatal care: Ensure that pregnant women have easy access to regular check-ups and screenings to monitor their health and the health of their unborn child.

2. Improve availability of malaria prevention and treatment: Implement strategies to prevent and treat malaria during pregnancy, such as distributing insecticide-treated bed nets and providing antimalarial medications.

3. Enhance health education and awareness: Conduct educational campaigns to raise awareness about the importance of maternal health and the risks associated with malaria during pregnancy. This can include providing information on preventive measures and the benefits of early detection and treatment.

4. Strengthen healthcare infrastructure: Invest in improving healthcare facilities, particularly in areas with high malaria prevalence. This can involve increasing the number of skilled healthcare providers, improving laboratory capabilities for malaria diagnosis, and ensuring the availability of essential medical supplies.

To simulate the impact of these recommendations on improving access to maternal health, a methodology could include the following steps:

1. Define the target population: Determine the specific group of pregnant women who would benefit from the recommendations, such as those living in malaria-endemic areas.

2. Collect baseline data: Gather information on the current access to maternal health services, prevalence of malaria during pregnancy, and relevant health outcomes, such as maternal and neonatal mortality rates.

3. Develop a simulation model: Create a mathematical or computational model that represents the population and the various factors influencing access to maternal health. This model should incorporate variables such as healthcare infrastructure, availability of preventive measures and treatment, and health-seeking behaviors.

4. Input data and parameters: Use the collected baseline data to populate the simulation model with relevant information, such as the number of pregnant women, their demographic characteristics, and the current utilization of maternal health services.

5. Implement recommendations: Introduce the proposed recommendations into the simulation model by adjusting relevant parameters, such as increasing the availability of antenatal care or distributing bed nets.

6. Simulate outcomes: Run the simulation model to project the potential impact of the recommendations on access to maternal health. This can include estimating changes in the number of pregnant women receiving antenatal care, reductions in malaria prevalence, and improvements in health outcomes.

7. Analyze results: Evaluate the simulated outcomes to assess the effectiveness of the recommendations in improving access to maternal health. This can involve comparing the projected outcomes with the baseline data to determine the magnitude of the impact.

8. Refine and iterate: Based on the analysis of the simulation results, refine the model and adjust the recommendations as needed. Repeat the simulation process to further explore different scenarios and optimize the strategies for improving access to maternal health.

It’s important to note that the specific methodology for simulating the impact of recommendations may vary depending on the available data, resources, and expertise.

Yabelana ngalokhu:
Facebook
Twitter
LinkedIn
WhatsApp
Email